https://www.selleckchem.com/products/pf-9366.html
To determine feasibility of providing a concentrated emulsified long-chain polyunsaturated fatty acids (LCPUFA) supplement to very low birth weight infants, and to evaluate blood LCPUFA concentrations at 2 and 8weeks of study supplementation. This prospective, randomized, double-blind, placebo-controlled trial randomized infants to receive (1) LCPUFA-120 (a supplement of 40mg/kg/day docosahexaenoic acid [DHA] and 80mg/kg/day arachidonic acid [ARA]; DHAARA at 12 ratio), (2) LCPUFA-360 (a supplement of 120mg/kg/day DHA and 240mg/kg/day AR
Suka
Komentar
Membagikan
